𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Precautions to improve the accuracy of quantitative determinations of biomarkers in clinical diagnostics

✍ Scribed by Nasim Ghasemzadeh; Tore W. Wilhelmsen; Fred Nyberg; Stellan Hjertèn

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
167 KB
Volume
31
Category
Article
ISSN
0173-0835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improving accuracy in the grading of ren
Improving accuracy in the grading of renal cell carcinoma by combining the quantitative description of chromatin pattern with the quantitative determination of cell kinetic parameters
✍ Christine François; Christophe Moreno; Joel Teitelbaum; Gilbert Bigras; Isabelle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 1 views

The determination of grade and stage in renal cell carcinomas (RCCs) often fails to predict the actual clinical outcome for individual patients. The aim of the present work was to investigate whether it is possible to significantly improve the prognostic accuracy of the grading system by using the c

Clinical utility of the transpulmonary e
Clinical utility of the transpulmonary echo enhancing agent Levovist to improve diagnostic confidence in echocardiography
✍ Nanda, Navin C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 877 KB

Echo enhancing agents have been used in echocardiography since 1968 for a variety of applications. Until recently, the agents were unable to survive transit through the pulmonary circulation following intravenous injection, and the technique was therefore restricted to investigations of the right si

CSF protein biomarkers for proximal axon
CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome
✍ A. Petzold; J. Brettschneider; K. Jin; G. Keir; N.M.F. Murray; N.P. Hirsch; Y. I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

## Abstract Early predictors of prognosis in Guillain‐Barré syndrome (GBS) are needed to identify patients who are likely to make a poor recovery and to guide therapeutic decision‐making in the acute phase. Here we investigate whether axonal protein biomarkers released into the cerebrospinal fluid